Current Cancer Therapeutics, Fourth Edition, written by more than 60 renowned authors, provides an insightful guide to the overwhelming influx of knowledge on an array of cancer types, as well as protocols for treatment and supportive care. Divided into four easy-to-read sections; healthcare professionals can easily find key data on pharmacokinetics, drug indications, and toxicities, plus concise summaries of epidemiology and comprehensive management guidance for complications such as hematological, neurological, and cardiopulmonary toxicities. Cutting-edge information, paired with a variety of professionally prepared tables and charts, makes this an unparalleled resource for all healthcare professionals working with this complex disease.
|
There is a newer edition of this item:
|
Book Description
Editorial Reviews
About the Author
Editor #1: John M. Kirkwood, MD:
Professor and Chief, Division of Medical Oncology, University of Pittsburgh School of Medicine; Chief Melanoma Center, University of Pittsburgh Cancer Institute, Pittsburgh, PA--
Professor and Chief, Division of Medical Oncology, University of Pittsburgh School of Medicine; Chief Melanoma Center, University of Pittsburgh Cancer Institute, Pittsburgh, PA--
Editor #2: Michael T. Lotze, MD:
Smith Kline Beecham Pharmaceuticals Vice President and Director, Departments of Inflammation, Tissue Repair, and Oncology, King of Prussia, PA--
Editor #3: Joyce M. Yasko, PhD:
Professor, School of Nursing, University of Pittsburgh Associate Director, Clinical and Network Programs, University of Pittsburgh Cancer Institute, Pittsburgh, PA
Product Details
Would you like to update product info or give feedback on images?
|
Customer Reviews
|
There are no customer reviews yet.
|
|||
|
Video reviews
|
Inside This Book
(learn more)
Key Phrases - Statistically Improbable Phrases (SIPs):
(learn more)
staging criteria, fluorinated uracil analogue, including differential leukocyte count, aggressive visceral disease, adjustments for organ dysfunction, cycles for adjuvant therapy, causing transcription errors, following disease relapse, aldesleukin therapy, antiemetics before chemotherapy, renal function indices, small noncleaved cell lymphomas, false incorporation, cancer clinical research, serious infection develop, possible skin reactions, plasma cell labeling index, cumulative doxorubicin dose, monitor blood counts, randomized intergroup trial, unknown primary carcinoma, toxicity grading, antimetabolic effects, histopathologic grade, combination with cisplatin Key Phrases - Capitalized Phrases (CAPs): (learn more)
Clin Oncol, Cancer Inst, Semin Oncol, United States, Ann Oncol, Ann Intern Med, Eastern Cooperative Oncology Group, Ann Surg, Southwest Oncology Group, Cancer Res, New York, Arch Pathol Lab Med, Radiation Therapy Oncology Group, Lippincott-Raven Publishers, Study Patients, Oncol Biol Phys, Collaborative Group, Cancer Treat Rep, Cancer Chemother Pharmacol, Arch Surg, Immune Defic Syndr, Bristol-Meyers Squibb, Gynecol Oncol, Research Triangle Park, Study Evaluable Patients New!
Concordance | Text Stats Browse Sample Pages:
Front Cover | Table of Contents | First Pages | Index | Back Cover | Surprise Me!
staging criteria, fluorinated uracil analogue, including differential leukocyte count, aggressive visceral disease, adjustments for organ dysfunction, cycles for adjuvant therapy, causing transcription errors, following disease relapse, aldesleukin therapy, antiemetics before chemotherapy, renal function indices, small noncleaved cell lymphomas, false incorporation, cancer clinical research, serious infection develop, possible skin reactions, plasma cell labeling index, cumulative doxorubicin dose, monitor blood counts, randomized intergroup trial, unknown primary carcinoma, toxicity grading, antimetabolic effects, histopathologic grade, combination with cisplatin Key Phrases - Capitalized Phrases (CAPs): (learn more)
Clin Oncol, Cancer Inst, Semin Oncol, United States, Ann Oncol, Ann Intern Med, Eastern Cooperative Oncology Group, Ann Surg, Southwest Oncology Group, Cancer Res, New York, Arch Pathol Lab Med, Radiation Therapy Oncology Group, Lippincott-Raven Publishers, Study Patients, Oncol Biol Phys, Collaborative Group, Cancer Treat Rep, Cancer Chemother Pharmacol, Arch Surg, Immune Defic Syndr, Bristol-Meyers Squibb, Gynecol Oncol, Research Triangle Park, Study Evaluable Patients New!
Concordance | Text Stats Browse Sample Pages:
Front Cover | Table of Contents | First Pages | Index | Back Cover | Surprise Me!
Citations (learn more)
2
books
cite this book:
- Angiogenesis: From Basic Science to Clinical Applications by Napoleone Ferrara on page 223
- Tumor Bone Diseases and Osteoporosis in Cancer Patients: Pathophysiology, Diagnosis, and Therapy by Jean-Jac Body on page 261
Tag this product(What's this?)Think of a tag as a keyword or label you consider is strongly related to this product.
Tags will help all customers organize and find favorite items. |
Sell a Digital Version of This Book in the Kindle Store
If you are a publisher or author and hold the digital rights to a book, you can sell a digital version of it in our Kindle Store.
Learn more
Customer Discussions
|
This product's forum
Active discussions in related forums
Search Customer Discussions
|
Related forums
|
